Back

Antiarrhythmic effects of Sacubitrilat (LBQ657) on Ca2+ homeostasis in ventricular cardiomyocytes

2 September 2019 (12:40 - 13:30)
Organised by:
Congress Presentation Part of: Novel anti-arrhythmic therapies Arrhythmias ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Joerg Eiringhaus

Elbe Clinic Buxtehude, Buxtehude (Germany)

5 More presentations in this session

Presentation thumbnail
Gene therapy for cardiac conduction system dysfunction in heart failure
Mr L. Stuart (Manchester, GB)
Abstract
Presentation thumbnail
Low dose of quinidine is effective to normalize the slow inactivation in mutant Kv4.3 channel identified in an early repolarization syndrome patient
Doctor K. Takayama (Suita, JP)
Abstract Slides
Presentation thumbnail
Zebrafish models for arrhythmogenic cardiomyopathy type 8: a starting platform for exercise stress test and drug treatment
Doctor G. Beffagna (Padova, IT)
Abstract Slides
Presentation thumbnail
Carvedilol treatment diminishes spontaneous calcium release and electrical activity in human atrial myocytes
Ms V. Jimenez Sabado (Barcelona, ES)
Abstract
Presentation thumbnail
Dantrolene reduces CaMKII-mediated arrhythmogenesis
Doctor J. Mustroph (Regensburg, DE)
Abstract Slides

Access the full session

Session thumbnail
Novel anti-arrhythmic therapies

The Event

Event poster

ESC Congress 2019

2 September 2019 12:40 CET
You may be interested in
thumbnail
Congress Session
Risk stratification
thumbnail
Congress Session
Malignant arrhythmias
thumbnail
Congress Session
Novel arrhythmia treatments

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources